# Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)

> **NCT00739050** · PHASE4 · TERMINATED · sponsor: **Organon and Co** · enrollment: 4 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** simvastatin
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00739050
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09-19
- **Primary completion:** 2008-02-01
- **Final completion:** 2008-02-01
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00739050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00739050, "Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00739050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*